We compared genomic features across 23 cancer types and confirmed previous cancer-type-specific observations while also providing novel biological findings, such as the clock-like molecular features, the prevalence of SV burden across different tumorigenic stages and the incidence of TEDs in treated patients. The gene discussed is CLOCK; the disease is cancer.